Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A N Kales

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
American Journal of Clinical Pathology|May 1, 1974
Letter: Protamine-corrected thrombin timeH Palkuti, A N Kales
Primary Care|September 1, 1980
Leukemia: a spectrum of diseasesR A Binder, A N Kales
The Journal of Clinical Endocrinology and Metabolism|August 1, 1970
Dietary calcium perturbations in patients with abnormal calcium depositionA N Kales, J M Phang
The Journal of Clinical Endocrinology and Metabolism|January 1, 1971
The effect of divided calcium intake on calcium metabolismA N Kales, J M Phang
Primary Care|September 1, 1979
Evaluation of anemiaR A Binder, A N Kales
Cancer|April 1, 1978
Simultaneous presentation of acute myelomonocytic leukemia and multiple myelomaB Cleary, R A Binder, A N Kales, et al.
Cancer Research|September 1, 1980
Cloning of human lymphocytes reactive with autologous leukemia cellsG Csako, R A Binder, A N Kales, et al.
Immunohematology|January 1, 1987
Cold autoimmune hemolytic anemia with auto-anti-AI specificity: 51chromium survival studiesM H McGinniss, R A Binder, A N Kales, et al.
Clinical Therapeutics|May 1, 1993
Efficacy and tolerability of imipenem-cilastatin versus ceftazidime plus tobramycin as empiric therapy of presumed bacterial infection in neutropenic cancer patientsJ A Miller, T Butler, R A Beveridge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Phase II study of fluorouracil, leucovorin, and interferon alfa-2a in metastatic colorectal carcinomaJ L Grem, E Jordan, M E Robson, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
American Journal of Clinical Pathology|May 1, 1974
Letter: Protamine-corrected thrombin timeH Palkuti, A N Kales
Primary Care|September 1, 1980
Leukemia: a spectrum of diseasesR A Binder, A N Kales
The Journal of Clinical Endocrinology and Metabolism|August 1, 1970
Dietary calcium perturbations in patients with abnormal calcium depositionA N Kales, J M Phang
The Journal of Clinical Endocrinology and Metabolism|January 1, 1971
The effect of divided calcium intake on calcium metabolismA N Kales, J M Phang
Primary Care|September 1, 1979
Evaluation of anemiaR A Binder, A N Kales
Cancer|April 1, 1978
Simultaneous presentation of acute myelomonocytic leukemia and multiple myelomaB Cleary, R A Binder, A N Kales, et al.
Cancer Research|September 1, 1980
Cloning of human lymphocytes reactive with autologous leukemia cellsG Csako, R A Binder, A N Kales, et al.
Immunohematology|January 1, 1987
Cold autoimmune hemolytic anemia with auto-anti-AI specificity: 51chromium survival studiesM H McGinniss, R A Binder, A N Kales, et al.
Clinical Therapeutics|May 1, 1993
Efficacy and tolerability of imipenem-cilastatin versus ceftazidime plus tobramycin as empiric therapy of presumed bacterial infection in neutropenic cancer patientsJ A Miller, T Butler, R A Beveridge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Phase II study of fluorouracil, leucovorin, and interferon alfa-2a in metastatic colorectal carcinomaJ L Grem, E Jordan, M E Robson, et al.
Pageof 2